Larry Herrera
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
-
- CAR-T cell therapy research
- Neutropenia and Cancer Infections
Papers in
-
- Toxin Mechanisms and Immunotoxins 5
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Eric Sandler (4 shared papers)Ellen S. Vitetta (3 shared papers)Roula Farah (2 shared papers)George R. Buchanan (3 shared papers)Victor Gheţie (4 shared papers)Birgitta Clinchy (1 shared paper)Deborah B. Aquino (2 shared papers)Victor M. Aquino (2 shared papers)
- Journals
- Cancer (2 papers)Leukemia (2 papers)Cancer Research (2 papers)Annals of Oncology (1 paper)Critical Reviews in Eukaryotic Gene Expression (1 paper)
- Partner nations
- United StatesPolandColombia
In The Last Decade
Larry Herrera
13 papers receiving 409 citations
Peers
Comparison fields: 5 of 57
- Hematology 90
- Oncology 164
- Immunology 126
- Genetics 61
- Biotechnology 52
Countries citing papers authored by Larry Herrera
This map shows the geographic impact of Larry Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Herrera more than expected).
Fields of papers citing papers by Larry Herrera
This network shows the impact of papers produced by Larry Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Herrera. The network helps show where Larry Herrera may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry Herrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 75 | |
| 2 | 2008 | 72 | |
| 3 | 1998 | 68 | |
| 4 | 2000 | 64 | |
| 5 | 2000 | 57 | |
| 6 | 2003 | 42 | |
| 7 | 2007 | 19 | |
| 8 | 2000 | 16 | |
| 9 | 2006 | 13 | |
| 10 | 2000 | 11 | |
| 11 | The anti-CD19 immunotoxin (HD37-dgRTA) is more effective when combined with chemotherapy | 2005 | 2 |
| 12 | 2016 | 1 | |
| 13 | 2000 | 1 |
About Larry Herrera
Larry Herrera is a scholar working on Immunology, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 13 papers that have together received 441 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer therapeutics and mechanisms (2 papers), Neuroblastoma Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Neutropenia and Cancer Infections (2 papers), Acute Myeloid Leukemia Research (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (90 citations), Oncology (164 citations), Immunology (126 citations), Genetics (61 citations) and Biotechnology (52 citations). Larry Herrera has collaborated with scholars based in United States, Poland and Colombia. Frequent co-authors include Eric Sandler, Ellen S. Vitetta, Roula Farah, George R. Buchanan, Victor Gheţie, Birgitta Clinchy, Deborah B. Aquino, Victor M. Aquino, E S Vitetta and Bruce Bostrom. Their work appears in journals such as Cancer, Leukemia, Cancer Research, Annals of Oncology and Critical Reviews in Eukaryotic Gene Expression.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.